Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects

BACKGROUND: A large body of evidence suggests that thyroid hormones (THs) are beneficial for the treatment of cardiovascular disorders. We have shown that 3 days of triiodo-L-thyronine (T3) treatment in myocardial infarction (MI) rats increased left ventricular (LV) contractility and decreased myocy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Rajagopalan, Viswanathan, Zhang, Youhua, Ojamaa, Kaie, Chen, Yue-feng, Pingitore, Alessandro, Pol, Christine J., Saunders, Debra, Balasubramanian, Krithika, Towner, Rheal A., Gerdes, A. Martin
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4794221/
https://ncbi.nlm.nih.gov/pubmed/26981865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0151413
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars